PPARγ antagonists reverse the inhibition of neural antigen-specific Th1 response and experimental allergic encephalomyelitis by Ciglitazone and 15-Deoxy-Δ12,14-Prostaglandin J2

« Previous Next »Journal of Neuroimmunology
Volume 178, Issue 1 , Pages 76-86, September 2006

PPARγ antagonists reverse the inhibition of neural antigen-specific Th₁ response and experimental allergic encephalomyelitis by Ciglitazone and 15-Deoxy-Δ^12,14-Prostaglandin J₂

Himanshu P. Raikwar
- Department of Neurology, Vanderbilt University Medical Center, Nashville, TN 37212, USA
Gladson Muthian
- Department of Neurology, Vanderbilt University Medical Center, Nashville, TN 37212, USA
Johnson Rajasingh
- Department of Neurology, Vanderbilt University Medical Center, Nashville, TN 37212, USA
Caroline N. Johnson
- Department of Neurology, Vanderbilt University Medical Center, Nashville, TN 37212, USA
John J. Bright
- Department of Neurology, Vanderbilt University Medical Center, Nashville, TN 37212, USA
- Department of Pharmacology, Vanderbilt University Medical Center, Nashville, TN 37212, USA
- Methodist Research Institute, Clarian Health Partners, Indianapolis, IN 46202, USA
- Corresponding author. Methodist Research Institute, Clarian Health Partners 1800 N Capital Ave, Noyes Bldg E-504C, Indianapolis, IN 46202, USA. Tel.: +1 317 962 8722; fax: +1 317 962 9369.